Eric Schadt, PhD, on Predicting Disease Risk for Patients with Cancer

December 11, 2020
Hannah Slater

The founder and CEO of Sema4 spoke about what health care providers currently lack in preventing and treating diseases and what the reality of early detection and disease prevention can provide to patients with cancer.

The current health care system uses basic tests to collect a fraction of the information available for predicting disease risk and changes in an individual’s health.

However, according to the developers of Sema4, a patient-centered health intelligence company, the data generated during routine testing and episodic physician visits is limited and inadequate for determining a patient’s risk in advance of the acute onset of disease.

In an interview with CancerNetwork®, Eric Schadt, PhD, founder and CEO of Sema4, as well as the dean for Precision Medicine and professor of Predictive Health and Computational Biology at the Icahn School of Medicine at Mount Sinai, Schadt discussed what health care providers currently lack in preventing and treating diseases and what the reality of early detection and disease prevention can provide to patients with cancer.

This segment comes from the CancerNetwork® portion of the MJH Life Sciences Medical World News, airing daily on all MJH Life Sciences channels.

Reference:

Sema4. Our Story. Sema4 website. Published 2020. Accessed December 3, 2020. https://sema4.com/our-story/